Eli Lilly and Company

Politician(s) lobbied: Maeve von Heynitz (Director General), Department of Foreign Affairs; John Newham (Assistant Secretary), Department of Enterprise, Trade and Employment; Amii McKeever (Special Advisor), Department of Further and Higher Education, Research, Innovation and Science; John Shaw (Assistant Secretary), Department of the Taoiseach; James O'Connor (TD), Dáil Éireann, the Oireachtas; Jack Chambers (Minister), Department of Public Expenditure, National Development Plan Delivery and Reform; Stephen Kinsella (Special Adviser), Department of the Taoiseach; Conor Glynn (Special Advisor to the Tanaiste), Department of the Taoiseach; Simon Harris (Tánaiste and Minister), Department of Finance

Intent: To raise awareness amongst stakeholders of how Ireland can remain competitive as a destination for future global life sciences investment, by ensuring that pharmaceutical innovation is valued at all stages of the value chain, including measures to increase support for research development activities, infrastructure to support resilient manufacturing supply, and timely access to innovative medicines for Irish patients.

Methods: EmailLetterMeeting

Politician(s) lobbied: Muiris O’Connor (Assistant Secretary), Department of Health

Intent: To provide stakeholders with an understanding on emerging trends in scientific/clinical research.

Methods: Email

Politician(s) lobbied: James Lawless (Minister), Department of Further and Higher Education, Research, Innovation and Science; William Beausang (Assistant Secretary), Department of Further and Higher Education, Research, Innovation and Science; Amii McKeever (Special Advisor), Department of Further and Higher Education, Research, Innovation and Science

Intent: To raise awareness of the important role that highly educated PhD scientists play in the success of the pharma sector in Ireland , and ensure that there is a continued supply of such world-class graduates in the future

Methods: Meeting

Politician(s) lobbied: Muiris O’Connor (Assistant Secretary), Department of Health

Intent: To request a meeting with a senior Lilly scientist visiting from the US, on the topic of scientific research and innovation.

Methods: Email

Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; John Newham (Assistant Secretary), Department of Enterprise, Trade and Employment; Simon Harris (Tánaiste and Minister), Department of Finance; John Hogan (Secretary General), Department of Finance; Declan Hughes (Secretary General), Department of Enterprise, Trade and Employment; Ken O'Flynn (TD), Dáil Éireann, the Oireachtas; Colm Burke (TD), Dáil Éireann, the Oireachtas; Martin Daly (TD), Dáil Éireann, the Oireachtas; Maria Byrne (Senator), Seanad; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas

Intent: To raise awareness amongst stakeholders of the importance of policy cohesion and a whole-of-government approach in the development of the National Life Sciences Strategy, to ensure that Ireland has a competitive policy landscape for the life sciences sector into the future.

Methods: Event / ReceptionInformal communicationMeeting

Politician(s) lobbied: Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas

Intent: To see the government quickly engage in negotiations on a new framework agreement for the supply of innovative medicines for patients in Ireland, and to inform the government of the importance of the valuing medicines innovation at all stages of the pharmaceutical value-chain.

Methods: Phone call

Politician(s) lobbied: John Newham (Assistant Secretary), Department of Enterprise, Trade and Employment

Intent: To highlight the need for European policies that promote investment in scientific research and development, and manufacturing of innovative medicines in Europe, through strong protection of intellectual property rights.

Methods: EmailMeeting

Politician(s) lobbied: Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Geraldine Byrne Nason (Ambassador), Department of Foreign Affairs; Joseph Hackett (Secretary General), Department of Foreign Affairs

Intent: To highlight the complexity of global supply chains in the pharmaceutical industry and the risk of disruption those supply chains that tariffs may cause. ::To highlight the need for pro-business government policies that value innovation and support the continued strong footprint of innovative biopharma manufacturing in Ireland.

Methods: Virtual Meeting

Politician(s) lobbied: John Callinan (Secretary General), Department of the Taoiseach; John Newham (Assistant Secretary), Department of Enterprise, Trade and Employment

Intent: To highlight importance of maintaining EU competitiveness for global pharmaceutical investment in research, development & manufacturing through protection of IP rights & balanced environmental regulation in EU,

Methods: Meeting

Politician(s) lobbied: Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas; Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Geraldine Byrne Nason (Ambassador), Department of Foreign Affairs

Intent: To highlight the need for European policies that promote investment in scientific research and development, and manufacturing of innovative medicines in Europe, through strong protection of intellectual property rights and balanced environmental regulation including PFAS, Urban Waste Water Treatment Directive. ::To highlight the importance of reliable global supply chains in the pharmaceutical industry and the risk of tariffs to the disruption those supply chains.

Methods: Event / ReceptionPhone call